Health Care
Companies operating within the Health Care industry, ranked by market capitalization.
| Ticker | Exchange | Company Name | Last Price | % Change | Volume | Market Cap |
|---|---|---|---|---|---|---|
| CTKB | NASDAQ | Cytek BioSciences | $4.56 | +2.70% | 635K | $567.72M |
| PHR | NYSE | Phreesia | $9.21 | -1.71% | 1M | $564.89M |
| LXRX | NASDAQ | Lexicon Pharmaceuticals | $1.61 | +3.87% | 2M | $563.27M |
| NPCE | NASDAQ | NeuroPace | $16.86 | +1.93% | 195K | $550.91M |
| SLDB | NASDAQ | Solid Biosciences | $7.26 | +2.98% | 767K | $549.27M |
| PROK | NASDAQ | ProKidney | $1.90 | +4.40% | 525K | $547.52M |
| ZVRA | NASDAQ | Zevra Therapeutics | $10.17 | +5.17% | 744K | $544.4M |
| RGLS | NASDAQ | Regulus Therapeutics | $0.00 | 0.00% | NaN | $540.55M |
| RLMD | NASDAQ | Relmada Therapeutics | $7.52 | +2.04% | 958K | $540.47M |
| RIGL | NASDAQ | Rigel Pharmaceuticals | $28.90 | -1.10% | 252K | $530.38M |
| MLAB | NASDAQ | Mesa Laboratories | $100.00 | +4.43% | 121K | $528.82M |
| OCGN | NASDAQ | Ocugen | $1.73 | +2.98% | 5M | $524.7M |
| ANL | NASDAQ | Adlai Nortye | $14.27 | +1.28% | 621K | $519.4M |
| SIBN | NASDAQ | SIBONE | $12.39 | +3.86% | 457K | $517.66M |
| EMBC | NASDAQ | Embecta | $9.15 | +5.05% | 737K | $509.65M |
| XOMA | NASDAQ | XOMA | $40.94 | -0.12% | 996K | $507.58M |
| TECX | NASDAQ | AvroBio | $27.97 | +3.32% | 231K | $506.65M |
| FDMT | NASDAQ | 4D Molecular Therapeutics | $8.87 | +0.68% | 594K | $503.36M |
| TCMD | NASDAQ | Tactile Systems Technology | $23.02 | +2.31% | 334K | $502.55M |
| SGP | NASDAQ | SpyGlass Pharma | $22.94 | +3.66% | 71K | $498.73M |
| UPB | NASDAQ | Upstream Bio | $9.18 | -0.11% | 508K | $496.61M |
| AQST | NASDAQ | Aquestive Therapeutics | $4.10 | +1.23% | 976K | $494.11M |
| CYRX | NASDAQ | CryoPort | $10.26 | +4.69% | 387K | $490.68M |
| TRDA | NASDAQ | Entrada Therapeutics | $13.50 | +6.13% | 149K | $486.15M |
| ACRS | NASDAQ | Aclaris Therapeutics | $4.34 | -2.91% | 1M | $484.3M |
| FULC | NASDAQ | Fulcrum Therapeutics | $7.13 | -0.28% | 883K | $476.19M |
| ALLO | NASDAQ | Allogene Therapeutics | $2.13 | +0.95% | 7M | $474.18M |
| ENGN | NASDAQ | enGene Holdings | $7.27 | +3.27% | 729K | $471.57M |
| ADCT | NYSE | Adc Therapeutics SA | $3.78 | 0.00% | 799K | $468.26M |
| KMDA | NASDAQ | Kamada | $8.14 | +0.37% | 48K | $466.37M |
| AGL | NYSE | Agilon Health | $27.95 | +0.22% | 366K | $462.51M |
| VREX | NASDAQ | Varex Imaging | $11.65 | +5.62% | 298K | $459.95M |
| FLGT | NASDAQ | Fulgent Genetics | $15.19 | +2.64% | 409K | $457.5M |
| MDXG | NASDAQ | Mimedx Group | $3.36 | +8.91% | 2M | $456.9M |
| ESPR | NASDAQ | Esperion Therapeutics | $2.00 | +4.71% | 6M | $456.61M |
| OFIX | NASDAQ | Orthofix Medical | $11.76 | +2.35% | 209K | $455M |
| DNA | NYSE | Ginkgo Bioworks Holdings | $8.46 | +12.80% | 801K | $454.43M |
| STTK | NASDAQ | Shattuck Labs | $7.15 | +0.85% | 396K | $448.65M |
| PSNL | NASDAQ | Personalis | $5.52 | +9.52% | 2M | $447.57M |
| PACB | NASDAQ | Pacific Biosciences of California | $1.59 | +8.16% | 8M | $443.8M |
| BBNX | NASDAQ | Beta Bionics | $10.20 | +3.03% | 962K | $439.38M |
| ANGO | NASDAQ | Angiodynamic | $10.94 | +2.63% | 238K | $439.38M |
| LYEL | NASDAQ | Lyell Immunopharma | $19.73 | -4.22% | 64K | $437.1M |
| MYGN | NASDAQ | Myriad Genetics | $4.75 | +1.50% | 984K | $436.24M |
| VALN | NYSE EURONEXT - EURONEXT PARIS | Valneva SE | $5.38 | +0.94% | 105K | $432.79M |
| AURA | NASDAQ | Aura Biosciences | $7.05 | +4.75% | 219K | $427.38M |
| RGNX | NASDAQ | Regenxbio | $8.97 | +6.79% | 622K | $425.23M |
| TLRY.TO | NASDAQ | Tilray Brands Inc | $8.47 | +0.47% | 2M | $424.87M |
| AVIR | NASDAQ | Atea Pharmaceuticals | $5.51 | +1.47% | 254K | $424.23M |
| SRTA | NASDAQ | Strata Critical Medical Cl A Com | $5.02 | +2.45% | 618K | $423.2M |